SCHEMBL2907586

SCHEMBL2907586

O=C(NC1CCCCC1)C(C1CCCCC1)C1(Cc2ccccc2)Nc2cc(F)c(Cl)cc2N1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 2/20 0.41
HPGD P15428 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
EPHX2 P34913 4/20 0.40
MDM2 Q00987 2/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
CYP3A4 P08684 1/20 0.40
KCNH2 Q12809 1/20 0.40
NR1H4 Q96RI1 1/20 0.40
ALDH1A1 P00352 2/20 0.39
NPC1 O15118 4/20 0.38
RAB9A P51151 4/20 0.38
KMT2A Q03164 2/20 0.38
ACKR3 P25106 1/20 0.38
MEN1 O00255 1/20 0.37
TP53 P04637 1/20 0.37
TSHR P16473 1/20 0.37
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2915607 0.87 EPHX1 (0.48) EPHX1HPGDTDP1EPHX2SMN1; SMN2
SCHEMBL2912657 0.86 EPHX2 (0.51) EPHX1HPGDEPHX2MDM2NPC1
SCHEMBL3652322 0.86 CYP3A4 (0.37) EPHX1HPGDTDP1EPHX2MDM2
SCHEMBL3653137 0.84 P4HB (0.40) TDP1EPHX2SMN1; SMN2CYP3A4KCNH2
SCHEMBL3654059 0.83 EPHX1 (0.44) EPHX1HPGDTDP1EPHX2SMN1; SMN2
SCHEMBL3652035 0.82 EPHX2 (0.47) EPHX1HPGDTDP1EPHX2SMN1; SMN2
SCHEMBL2912425 0.81 TSHR (0.40) EPHX1SMN1; SMN2CYP3A4KCNH2NR1H4
SCHEMBL2907059 0.80 C3AR1 (0.39) EPHX1HPGDTDP1SMN1; SMN2ALDH1A1
SCHEMBL2912392 0.80 EPHX2 (0.48) EPHX1HPGDEPHX2MDM2NPC1
SCHEMBL3649241 0.80 NR1H4 (0.45) EPHX1MDM2SMN1; SMN2CYP3A4KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2222645-A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS F. Hoffmann-La Roche AG (CH) 2010-09-01 EP claimed
WO-2009062874-A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2009-05-22 WO claimed
EP-2222645-A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS F. Hoffmann-La Roche AG (CH) 2010-09-01 EP disclosed
WO-2009062874-A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2009-05-22 WO disclosed